send_thumbnail.jpg

Masao Murakami, M.D., Ph.D.

Radiation Oncologist
Director, Southern TOHOKU Proton Beam Therapy Center

  • Present Title & Affiliation

    • Director, Southern TOHOKU Proton Beam Therapy Center
    • Specially-appointed Professor, School of Medicine, Dokkyo Medical University, Japan

  • Education

    • 1982 M.D.

      Kobe University School of Medicine, Japan

    • 1990 Ph.D.

      Division of Radiology, Kobe University Graduate School of Medicine, Japan

  • Certifications

    • 1987

      Board-certified Radiologist by Japan Radiological Society (JRS)

    • 1999

      Board-certified Radiation Oncologist by Japanese Society for Radiation Oncology (JASTRO)

    • 2011

      Board-certified Radiation Oncologist by Japan Radiological Society (JRS) & Japanese Society for Radiation Oncology (JASTRO)

    • 2016

      Board-certified Radiology instructor by Japan Radiological Society (JRS)

  • Professional Experience

    • 1982-1983

      Junior Resident, Kobe University Hospital, Japan

    • 1983-1984

      Senior Resident, Kawasaki Medical School Hospital, Japan

    • 1984-1986

      Physician, Dept. of Radiology, Osaka Police Hospital, Japan

    • 1986-1988

      Lecturer, Dept. of Radiology, Kobe University School of Medicine, Japan

    • 1988-1999

      Deputy Director, Dept. of Radiation Oncology, Tenri Hospital, Japan

    • 1999-2001

      Deputy Director, Preparation Office for Hyogo Ion Beam Medical Center (HIBMC), Health and Welfare Dept., Hyogo Prefectural Government, Japan

    • 2001-2005

      Director, Dept. of Radiation Oncology, Hyogo Ion Beam Medical Center (HIBMC), Japan

    • 2005-2009

      Deputy Superintendent, Hyogo Ion Beam Medical Center (HIBMC), Japan

    • 2010-2012

      Superintendent, Hyogo Ion Beam Medical Center (HIBMC), Japan

    • 2010-2017

      Visiting Researcher, The National Institute of Biomedical Innovation (NIBIO), Japan 

    • 2010-2017

      Visiting Professor, Osaka University School of Medicine, Japan

    • 2010-2017

      Visiting Professor, Kobe University School of Medicine, Japan

    • 2012-2017

      Professor and Director, Dept. of Radiation Oncology, Dokkyo Medical University School of Medicine, Japan

    • 2012-2017

      Director, Radiation Oncology Center, Dokkyo Medical University Hospital, Japan

    • 2017-present

      Director, Southern TOHOKU Proton Beam Therapy Center, Japan

    • 2017-present

      Specially-appointed Professor, Dokkyo Medical University School of Medicine, Japan

  • Skill Highlights

    • Radiation therapy for malignant (cancerous) tumors
    • Particle radiotherapy for malignant (cancerous) tumors

  • Professional Memberships

    • 1982-present

      Japanese Radiological Society (JRS)

    • 1982-present

      The Japan Society of Clinical Oncology (JSCO)

    • 1982-present

      The Japan Lung Cancer Society (JLCS)

    • 1988-present

      Japanese Society for Radiation Oncology (JASTRO)

    • 1999-present

      Particle Therapy Co-Operative Group (PTCOG)

    • 2000-present

      The Japan Society for Head and Neck Cancer (JSHNC)         

  • Selected Publications

    • Nishizawa S, Higa T, Kuroda Y, Sano A, Murakami M, Takahashi Y: Increased accumulation of N-isopropyl(I-123)p-iodo amphetamine in bronchial carcinoid tumor. The Journal of Nuclear Medicine 31: 240-242, 1990.

    • Hishikawa Y, Miura T, Oshitani T, Yoshimura H, Ono K, Takahashi M, Nakajima T, Murakami M, Chatani M, Inoue T: A randomized prospective study of adjuvant chemotherapy after radiotherapy in unresectable esophageal carcinoma. Disease of the esophagus 4: 85-90, 1991.
    • Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H: Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 40: 1049-59, 1998.
    • Hiroaki Saura, Kuniaki Ogasawara, Takaaki Beppu, Koji Yoshida, Masakazu Kobayashi, Kenji Yoshida, Kazunori Terasaki, Yoshihiro Takai, Akira Ogawa, Hypoxic viable tissue in human chronic cerebral ischemia because of unilateral major cerebral artery stenoocclusive disease.  Stroke 2015; 46:1250-1256
    • Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Matsusue S, Takeda H: Comparison between chemoradiation protocol intended to organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 45: 277-284, 1999.
    • Sasaki R, Murakami M, Okamoto Y, Kono K, Yoden E, Nakajima T, Nabeshima S, Kuroda Y:  The efficacy of conventional radiation therapy in the management of pituitary adenoma. Int J Radiat Oncol Biol Phys 47: 1337-45, 2000.
    • Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Matsusue S, Takeda H: Treatment results of esophageal carcinoma of clinical T3,T4M0: definitive chemoradiotherapy, neoadjuvant chemoradiotherapy followed by surgery and conventional surgery in 75 cases. Oncol Rep 7: 571-8, 2000.
    • Okamoto Y, Murakami M, Kuroda M, Mizowaki T, Nakajima T, Kusumi F, Hajiro K, Matsusue S, Takeda H, Kobashi Y: Mismatched clinicopathological response after concurrent chemoradiotherapy for thoracic esophageal cancer.  Disease of the esophagus 13: 80-86, 2000.
    • Murakami M, Kuroda Y, Nishimura S, Sano S, Okamoto Y, Taniguchi T, Nakajima T, Kobashi Y, Matsusue S: Intraarterial infusion chemotherapy and radiotherapy with/without surgery for patients with locally advanced or recurrent breast cancer. Am J Clin Oncol 24: 185-191, 2001.
    • Hishikawa Y, Kagawa K, Murakami M, Sakai H, Akagi T, Abe M: Usefulness of positron-emission tomographic images after proton therapy. Int J Radiat Oncol Biol Phys 53: 1388-1391, 2002.
    • Sasaki R, Soejima T, Kishi K, Imajo Y, Hirota S, Kamikonya N, Murakami M, Kawabe T, Ejima Y, Matsumoto A, Sugimura K: Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome. Int J Radiat Oncol Biol Phys 52: 1032-40. 2002.
    • Kagawa K, Murakami M, Hishikawa Y, Abe M, Akagi T, Yanou T, Kagiya G, Furusawa Y, Ando K, Nojima K, Aoki M, Kanai T: Preclinical biological assessment of proton and carbon ion beams at Hyogo Ion Beam Medical Center.  Int J Radiat Oncol Biol Phys 54: 928-938, 2002.
    • Hishikawa Y, Kagawa K, Murakami M, Itano A, Akagi T, Suga D, Abe M: The cancer treatment system at Hyogo Ion Beam Medical Center (HIBMC). Jpn Soc Radiat Oncol 14: 73-77, 2002.
    • Okamoto Y, Murakami M, Yoden E, Sasaki R, Okuno Y, Nakajima T, Kuroda Y.: Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys. 52: 390-6, 2002.
    • Hishikawa Y, Kagawa K, Murakami M, Itano A, Akagi T, Suga D, Abe M: The ion beam treatment system and the results of clinical trial at the Hyogo Ion Beam Medical Center (HIBMC). Particles 31: 7-8, 2003.
    • Hara I, Murakami M, Kagawa K, Sugimura K, Kamidono S, Hishikawa Y, Abe M: Experience with conformal proton therapy for early prostate cancer. Am J Clin Oncol. 27: 323-327, 2004.
    • Hishikawa Y, Oda Y, Mayahara H, Kawaguchi A, Kagawa K, Murakami M, Abe M: Status of the clinical work at Hyogo. Radiother Oncol 73 Suppl.2: 38-40, 2004.
    • Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, Takakuwa H, Matsusue S: Treatment results of chemo-radiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. Int J Radiat Oncol Biol Phys 64: 1106-1111, 2006.
    • Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T: Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncologica 45: 1120-1125, 2006.
    • Inui T, Asakawa A, Morita Y, Mizuno S, Natori T, Kawaguchi A, Murakami M, Hishikawa Y, Inui A: HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer. J Intern Med 260: 484-487, 2006.
    • Mayahara H, Murakami M, Kagawa K, Kawaguchi A, Oda Y, Miyawaki D, Sasaki R, Sugimura K, Hishikawa Y: Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center experience. Int J Radiat Oncol Biol Phys 69: 434-443, 2007.
    • Demizu Y, Murakami M, Miyawaki D, Niwa Y, Akagi T, Sasaki R, Terashima K, Suga D, Kamae I, Hishikawa Y: Analysis of vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves. Int J Radiat Oncol Biol Phys 75: 1487-1492, 2009.
    • Miyawaki D, Murakami M, Demizu Y, Sasaki R, Niwa Y, Terashima K, Nishimura H, Hishikawa Y, Sugimura K: Brain injury after proton therapy or carbon ion therapy for head and neck cancers and skull base tumors. Int J Radiat Oncol Biol Phys 75: 378-384, 2009.
    • Yogo A, Sato K, Nishikino M, Mori M, Teshima T, Numasaki H, Murakami M, Demizu Y, Akagi S, Nagayama S, Ogura K, Sagisaka A, Orimo S, Nishiuchi M, Pirozhkov AS, Ikegami M, Tampo M, Sakaki H, Suzuki M, Daito I, Oishi Y, Sugiyama H, Kiriyama H, Okada H, Kanazawa S, Kondo S, Shimomura T, Nakai Y, Tanoue M, Sasao H, Wakai D, Bolton PR, Daido H: Application of laser-accelerated protons to the demonstration of DNA double-strand breaks in human cancer cells. Applied Physics Letters 94, 181502: 1-3, 2009.
    • Ito A, Kai Y, Goto M, Takeo N, Okamoto O, Kato A, Shimizu F, Katagiri K, Fujiwara S, Miura T, Watanabe K, Murakami M: Successful treatment of single lymph node metastasis of melanoma with carbon ion radiotherapy and chemotherapy. Journal of Dermatology 36: 430-432, 2009.
    • Shimizu M, Sasaki R, Miyawaki D, Nishimura H, Demizu Y, Akagi T, Suga D, Sakamoto H, Murakami M, Sugimura K, Hishikawa Y: Physiologic reactions after proton beam therapy in patients with prostate cancer: significance of urinary autoactivation. Int J Radiat Oncol Biol Phys 75: 580-586, 2009.
    • Fukumoto T, Komatsu S, Hori Y, Murakami M, Hishikawa Y, KU Y: Particle beam radiotherapy with a surgical spacer placement for advanced abdominal leiomyosarcoma results in a significant clinical benefit. Journal of Surgical Oncology 101: 97-99, 2010.
    • Sutherland K, Miyajima S, Date H, Shirato H, Ishikawa M, Murakami M, Yamagiwa M, Bolton P, Tajima T: A parameter study of pencil beam proton dose distributions for the treatment of ocular melanoma utilizing spot scanning. Radiol Phys Thecnol 3: 16-22, 2010.
    • Komatsu S, Hori Y, Fukumoto T, Murakami M, Hishikawa Y, Ku Y: Surgical spacer placement and proton radiotherapy for unresectable hepatocellular carcinoma. World Journal of Gastroenterology 16: 1800-1803, 2010.
    • Iwata H, Murakami M, Demizu Y, Miyawaki D, Terashima K, Niwa Y, Mima M, Akagai T, Hishikawa Y, Shibamoto Y: High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer. Cancer 116: 2476-2485, 2010.
    • Komatsu S, Fukumoto T, Demizu Y, Miyawaki D, Terashima K, Niwa Y, Mima M, Fujii O, Sasaki R, Yamada I, Hori Y, Hishikawa Y, Abe M, Ku Y, Murakami M: The effectiveness of particle radiotherapy for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus. Journal of Gastroenterology 46: 913-920, 2011.
    • Komatsu S, Murakami M, Fukumoto T, Hori Y, Hishikawa Y, Ku Y: Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma. Br J Surg 98: 558–564, 2011.
    • Komatsu S, Fukumoto T, Demizu Y, Miyawaki D, Terashima K, Sasaki R, Hori Y, Hishikawa Y, Ku Y, Murakami M: Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. Cancer 117: 4890–4904, 2011.
    • Nihei K, Ogino T, Onozawa M, Murayama S, Fuji H, Murakami M, Hishikawa Y. Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities. Int J Radiat Oncol Biol Phys 81: 390-396, 2011.
    • Terashima K, Demizu Y, Hashimoto N, Jin D, Mima M, Fujii O, Niwa Y, Takatori K, Kitajima N, Sirakawa S, Yonson K, Hishikawa Y, Abe M, Sasaki R, Sugimura K, Murakami M. A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Radiother Oncol 103(1):25-31., 2012.
    • Nagano T, Kotani Y, Fujii O, Demizu Y, Niwa Y, Ohno Y, Nishio W, Itoh T, Murakami M, Nishimura Y. A case of acute exacerbation of idiopathic pulmonary fibrosis after proton beam therapy for non-small cell lung cancer. Jpn J Clin Oncol. 2012 Oct;42(10):965-9. Epub 2012 Jul 23.
    • Teshima T, Numasaki H, Nishio M, Ikeda H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Ando Y, Tsukamoto N, Terahara A, Nakamura K, Murakami M, Takahashi M, Nishimura T; Japanese Society for Therapeutic Radiology and Oncology Database Committee. Japanese structure survey of radiation oncology in 2009 based on institutional stratification of the Patterns of Care Study.       J Radiat Res. 2012 Sep;53(5):710-21. doi: 10.1093/jrr/rrs028. Epub 2012 Jul 5.
    • Tamaki Y, Sasaki R, Ejima Y, Ogura M, Negoro Y, Nakajima T, Murakami M, Kaji Y, Sugimura K. Efficacy of intraoperative radiotherapy targeted to the abdominal lymph node area in patients with esophageal carcinoma.       J Radiat Res. 2012 Nov 1;53(6):882-91. doi: 10.1093/jrr/rrs045. Epub 2012 Aug 7.
    • Numasaki H, Nishio M, Ikeda H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Ando Y, Tsukamoto N, Terahara A, Nakamura K, Nishimura T, Murakami M, Takahashi M, Teshima T; Japanese Society for Therapeutic Radiology and Oncology Database Committee. Japanese structure survey of radiation oncology in 2009 with special reference to designated cancer care hospitals. Int J Clin Oncol. 2013 Oct;18(5):775-83. doi: 10.1007/s10147-012-0468-7. Epub 2012 Sep 28.
    • Iwata H, Demizu Y, Fujii O, Terashima K, Mima M, Niwa Y, Hashimoto N, Akagi T, Sasaki R, Hishikawa Y, Abe M, Shibamoto Y, Murakami M, Fuwa N. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer. J Thorac Oncol. 2013 Jun;8(6):726-35. doi: 10.1097/JTO.0b013e318288ab02.
    • Fujii O, Demizu Y, Hashimoto N, Araya M, Takagi M, Terashima K, Mima M, Iwata H, Niwa Y, Jin D, Daimon T, Sasaki R, Hishikawa Y, Abe M, Murakami M, Fuwa N.  A retrospective comparison of proton therapy and carbon ion therapy for stage I non-small cell lung cancer. Radiother Oncol. 2013 Oct;109(1):32-7. doi: 10.1016/j.radonc.2013.08.038. Epub 2013 Sep 19.
    • Makita C, Nakamura T, Takada A, Takayama K, Suzuki M, Ishikawa Y, Azami Y, Kato T, Tsukiyama I, Kikuchi Y, Hareyama M, Murakami M, Fuwa N, Hata M, Inoue T. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma. Radiat Oncol. 2014 Jan 14; 9:26. doi: 10.1186/1748-717X-9-26.
    • Morimoto K, Demizu Y, Hashimoto N, Mima M, Terashima K, Fujii O, Otsuki N, Murakami M, Fuwa N, Nibu K. Particle radiotherapy using protons or carbon ions for unresectable locally advanced head and neck cancers with skull base invasion. Jpn J Clin Oncol. 2014 May;44(5):428-34. doi: 10.1093/jjco/hyu010. Epub 2014 Mar 11.
    • Aoki-Nakano M, Furusawa Y, Uzawa A, Matsumoto Y, Hirayama R, Tsuruoka C, Ogino T, Nishio T, Kagawa K, Murakami M, Kagiya G, Kume K, Hatashita M, Fukuda S, Yamamoto K, Fuji H, Murayama S, Hata M, Sakae T, Matsumoto H. Relative biological effectiveness of therapeutic proton beams for HSG cells at Japanese proton therapy facilities. J Radiat Res. 2014 Jul;55(4):812-5. doi: 10.1093/jrr/rru003. Epub 2014 Apr 3.
    • Sulaiman NS, Fujii O, Demizu Y, Terashima K, Niwa Y, Akagi T, Daimon T, Murakami M, Sasaki R, Fuwa N. Particle beam radiation therapy using carbon ions and protons for oligometastatic lung tumors., Radiat Oncol. 2014 Aug 16; 9:183. doi: 10.1186/1748-717X-9-183.
    • Takagi M, Demizu Y, Hashimoto N, Mima M, Terashima K, Fujii O, Jin D, Niwa Y, Morimoto K, Akagi T, Daimon T, Sasaki R, Hishikawa Y, Abe M, Murakami M, Fuwa N. Treatment outcomes of particle radiotherapy using protons or carbon ions as a single-modality therapy for adenoid cystic carcinoma of the head and neck. Radiother Oncol. 2014 Dec;113(3):364-70. doi: 10.1016/j.radonc.2014.11.031. Epub 2014 Nov 29.
    • Y. Demizu, O. Fujii, K. Terashima, M. Mima, N. Hashimoto, Y. Niwa, T. Akagi, T. Daimon, M. Murakami, N. Fuwa. Particle therapy for mucosal melanoma of the head and neck. Strahlenther Onkol 190:186–191 2014.
    • Akasaka H, Sasaki R, Miyawaki D, Mukumoto N, Sulaiman NS, Nagata M, Yamada S, Murakami M, Demizu Y, Fukumoto T. Preclinical evaluation of bioabsorbable polyglycolic acid spacer for particle therapy. Int J Radiat Oncol Biol Phys. 90(5):1177-85. doi: 10.1016/j.ijrobp.2014.07.048. 2014
    • Fujii O1, Demizu Y, Hashimoto N, Takagi M, Terashima K, Mima M, Jin D, Nagano F, Katsui K, Okimoto T, Iwata H, Niwa Y, Yamashita T, Akagi T, Daimon T, Sasaki R, Hishikawa Y, Abe M, Murakami M, Fuwa N. Particle therapy for clinically diagnosed stage I lung cancer: comparison with pathologically proven non-small cell lung cancer. Acta Oncol. 54(3):315-21. doi:10. 3109/0284186X. 2014. 974828.2015
    • M Mima, Y Demizu, D Jin, N Hashimoto, M Takagi, K Terashima, O Fujii, Y Niwa, T Akagi, T Daimon, Y Hishikawa, M Abe, M Murakami, R Sasaki, N Fuwa, Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma. Br J Radiol 87(1033):20130512. 2014.
    • Fujii O1, Demizu Y, Hashimoto N, Takagi M, Terashima K, Mima M, Jin D, Nagano F, Katsui K, Okimoto T, Iwata H, Niwa Y, Yamashita T, Akagi T, Daimon T, Sasaki R, Hishikawa Y, Abe M, Murakami M, Fuwa N. Particle therapy for clinically diagnosed stage I lung cancer: comparison with pathologically proven non-small cell lung cancer. Acta Oncol. 54(3):315-21. doi: 10.3109/0284186X.2014.974828. 2015.
    • Takagi M, Demizu Y, Terashima K, Fujii O, Jin D, Niwa Y, Daimon T, Murakami M, Fuwa N, Okimoto T. Long-term outcomes in patients treated with proton therapy for localized prostate cancer. Cancer Med. 2017 Oct;6(10):2234-2243. doi: 10.1002/cam4.1159. Epub 2017 Sep 6.
    • Ono T, Nakamura T, Yamaguchi H, Azami Y, Takayama K, Suzuki M, Wada H, Kikuchi Y, Murakami M, Nemoto K. Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer. Radiat Oncol. 2018 Feb 5;13(1):19. doi: 10.1186/s13014-018-0967-4.
      • Case Reports
    • Matsumoto S, Nishizawa S, Murakami M, Noma S, Sano A, Kuroda Y: Carmofur-induced leukoencephalopathy: MRI Neuroradiology 37: 649-652, 1995. 
    • Maetani Y, Murakami M, Kuroda Y, Kobashi Y, Maetani S: Recurrence of advanced gastric cancer presenting bone marrow carcinosis 18 years after surgery: report of a case. Tenri Medical Bulletisn 1: 79-87, 1998. 
    • Murakami M, Kuroda Y, Takeda H, Okamoto Y, Kono K, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Nakajima T, Matsusue S: Case report of 14-year survival after radiotherapy for clinical T3 esophageal carcinoma, with local recurrence finally rescued by surgery. Radiation Medicine 17: 459-462, 1999. 
    • Murakami M, Kuroda Y, Sano S, Okamoto Y, Nishimura S, Matsusue S, Takeda H: Breast conservation for huge sized locally advanced breast cancer: a case report. Radiation Medicine 19: 155-159, 2001. 
    • Murakami M, Kuroda Y, Sano S, Okamoto Y, Nishikawa T, Nishimura S, Matsusue S: Validity of local treatment including intraarterial infusion chemotherapy and radiotherapy for fungating adenocarcinoma of the breast: A case report of over 8 years survival. Am J Clin Oncol 24: 388-391, 2001. 
    • Mayahara H, Oda Y, Kawaguchi A, Kagawa K, Murakami M, Hishikawa Y, Igaki H, Tokuuye K, Abe M: A case of hepatocellular carcinoma initially treated by carbon ions, followed by protons for marginal recurrence with portal thrombus. Radiation Medicine 23: 513-519, 2005. 
    • Muroi H, Nakajima M, Satomura H, Takahashi M, Domeki Y, Murakami M, Nakamura T, Takada A, Kato H. Effectiveness of proton beam therapy on liver metastases of esophageal cancer: report of a case. Int Surg "100(1):180-4. doi: 10.9738/INTSURG-D-13-00188.1. 2015. 
      • Books
    • Murakami M, Hishikawa Y, Miyajima S, Okazaki Y, Sutherland KL, Abe M, Bulanov SV, Dido H, Esirkepov TZ, Koga J, Yamagiwa M, Tajima T: Radiotherapy using a laser proton accelerator. Laser-Driven Relativistic Plasmas Applied for Science, Industry, and Medicine, In: Bulanov SV, Daido H eds., pp275-300, AIP Conference, New York, 2008.
    • Murakami M, Demizu Y, Niwa Y, Miyawaki D, Terashima K, Arimura T, Mima M, Nagayama S, Maeda T, Baba M, Akagi T, Hishikawa Y, Abe M: Current status of the HIBMC and results of representative diseases. In: Bulanov SV, Daido H eds., pp400-415, AIP Conference 1153: New York, 2009.
    • Murakami M, Demizu Y, Niwa Y, Nagayama S, Maeda T, Baba M, Miyawaki D, Terashima K, Arimura T, Mima M, Akagi T, Daido H, Hishikawa Y, Abe M. Murakami, Current status of the hibmc, providing particle beam radiation therapy for more than 2,600 patients, and the prospects of laser-driven proton radiotherapy. In: Do¨ssel O, Schlegel WC, eds., pp878-882, WC 2009, IFMBE Proceedings, vol. 25. Berlin: Springer Berlin Heidelberg, 2009. 
    • Yogo A, Sato K, Nishikino M, Mori M, Teshima T, Numasaki H, Murakami M, Demizu Y, Akagi S, Nagayama S, Ogura K, Sagisaka A, Orimo S, Nishiuchi M, Pirozhkov AS, Ikegami M, Tampo M, Sakaki H, Suzuki M, Daito I, Oishi Y, Sugiyama H, Kiriyama H, Okada H, Kanazawa S, Kondo S, Shimomura T, Nakai Y, Tanoue M, Sasao H, Wakai D, Kawachi T, Nishimura H, Bolton PR, Daido H: Radiobiological study by using laser-driven proton beams. In: Bulanov SV, Daido H eds., pp438-447, AIP Conference 1153: 2009. 
    • Murakami M: Chapter 14 Clinical cases and results of proton-beam radiotherapy. The training program of professionals related to charged particle radiation therapy. The book for basic training course. In: The committee of the training program of professionals related to the charged particle radiation therapy eds., pp165-184, A commissioning enterprise of The Ministry of Education, Culture, Sports Science and Technology (MEXT). 2009. 
Back
Printer Friendly